Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal rod cell | 7 studies | 52% ± 18% | |
| retinal cone cell | 6 studies | 35% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 4 studies | 41% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 979.97 | 180 / 180 | 100% | 29.64 | 430 / 430 |
| uterus | 100% | 1024.35 | 170 / 170 | 100% | 52.52 | 459 / 459 |
| esophagus | 100% | 1138.21 | 1444 / 1445 | 100% | 27.75 | 183 / 183 |
| lung | 100% | 1044.40 | 578 / 578 | 100% | 32.21 | 1153 / 1155 |
| stomach | 100% | 1341.97 | 359 / 359 | 100% | 32.21 | 285 / 286 |
| intestine | 100% | 940.30 | 966 / 966 | 100% | 37.95 | 525 / 527 |
| brain | 100% | 1071.16 | 2631 / 2642 | 100% | 33.73 | 705 / 705 |
| skin | 100% | 1733.04 | 1809 / 1809 | 100% | 35.51 | 470 / 472 |
| adrenal gland | 100% | 1164.94 | 258 / 258 | 100% | 26.46 | 229 / 230 |
| thymus | 100% | 940.91 | 652 / 653 | 100% | 21.43 | 603 / 605 |
| pancreas | 100% | 657.57 | 328 / 328 | 99% | 26.73 | 177 / 178 |
| bladder | 100% | 994.24 | 21 / 21 | 99% | 40.73 | 501 / 504 |
| prostate | 100% | 1383.16 | 245 / 245 | 99% | 37.60 | 499 / 502 |
| breast | 100% | 959.85 | 459 / 459 | 99% | 34.27 | 1111 / 1118 |
| liver | 100% | 855.98 | 226 / 226 | 99% | 18.69 | 400 / 406 |
| kidney | 100% | 926.30 | 89 / 89 | 98% | 14.70 | 885 / 901 |
| adipose | 100% | 832.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 25.00 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 35.57 | 29 / 29 |
| spleen | 100% | 1320.14 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 48.28 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 52.21 | 1 / 1 |
| blood vessel | 99% | 602.71 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 527.69 | 844 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 534.12 | 787 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 65% | 491.89 | 607 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045202 | Cellular component | synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZMYND19 |
| Protein name | Zinc finger MYND domain-containing protein 19 (Melanin-concentrating hormone receptor 1-interacting zinc finger protein) (MCH-R1-interacting zinc finger protein) |
| Synonyms | MIZIP |
| Description | FUNCTION: May be involved as a regulatory molecule in GPR24/MCH-R1 signaling. |
| Accessions | ENST00000298585.3 Q96E35 |